Clinical Trial Update: Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lymphodepletion with ALLO-647 in adults with Relapsed/Refractory Large B-Cell Lymphoma undergoing ALLO-501A allogeneic CAR T therapy; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• ALLO-501A (anti-CD19 allogeneic CAR T cells)
• ALLO-647

Snippet

Sponsor: Allogene Therapeutics | Conditions: Relapsed/Refractory Large B Cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2025-12-31